Megan updates on the current timeline with respect to P3 data, approval and launch:
"Toplinedata from Phase 3 towards the end of 2023."
" 3Q2024 is on the cards for approval of this product."
"The second half of 2024 is realistic for launch."
Link (00:07:45-00:08:15):
Biotech Unlocked - OPTHEA ASX:OPT - YouTube
Ann: Opthea's OPT-302 Granted Fast-Track for wet AMD, page-63
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
84.5¢ |
Change
0.020(2.42%) |
Mkt cap ! $1.040B | |||
| Open | High | Low | Value | Volume |
| 82.0¢ | 85.5¢ | 80.5¢ | $1.108M | 1.338M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 121666 | 84.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 85.0¢ | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| OPT (ASX) Chart |